Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Creviston Steven ESVP, Connectivity & Sensors |  QRVOQorvo, Inc.Open-market sale · 10b5-1 plan | SELL | $188K 1,852 sh | Sep 3, 2026 |
| 22 | Kleinerman ChristianEVP, Product Management | SNOWSnowflake Inc. Open-market sale · 10b5-1 plan | SELL | $4.88M 15.0K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 22 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market purchase | BUY | $81.1 1 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 20 | Fukushima RyanCEO, Data |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $65K 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 20 | Wittmann MichaelChief Operating Officer |  INDIindie Semiconductor, Inc.Open-market sale · 10b5-1 plan | SELL | $66K 18.4K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 20 | Wittmann MichaelChief Operating Officer | INDIindie Semiconductor, Inc. Open-market sale · 10b5-1 plan | SELL | $80K 22.2K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 20 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $320K 11.5K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 19 | Llewellyn Lindsay CatherineSEE REMARKS |  LYFTLyft, Inc.Open-market sale · 10b5-1 plan | SELL | $220K 13.2K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 19 | Rodrigues Fernando M.President of BetterHelp |  TDOCTeladoc Health, Inc.Open-market sale · 10b5-1 plan | SELL | $34K 5,439 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 19 | Randhawa SimratEVP, Head of R&D |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $1.42M 13.3K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 19 | Fego Paul JSVP, Global Operations | QRVOQorvo, Inc. Open-market sale · 10b5-1 plan | SELL | $240K 2,400 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 18 | Le Pendeven YvesCFO |  FNKOFunko, Inc.Open-market sale · 10b5-1 plan | SELL | $222K 34.1K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 17 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $113K 4,075 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $4.96M 15.2K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 16 | Fego Paul JSVP, Global Operations | QRVOQorvo, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 100 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 15 | Guarini KathrynDirector |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $340K 400 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer |  LUNGPulmonx CorpOpen-market sale | SELL | $13K 5,863 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $54.02 2 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $821K 19.3K sh | Sep 3, 2026 traded Sep 3, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | LUNGPulmonx Corp Open-market sale | SELL | $8,177 3,618 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $746K 17.4K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | LUNGPulmonx Corp Open-market sale | SELL | $5,973 2,643 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | LUNGPulmonx Corp Open-market sale | SELL | $4,793 2,121 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $275K 6,348 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 13 | Enguent Jean-PierreVice President, R&DSS |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $36K 15.0K sh | Sep 3, 2026 traded Sep 3, 2026 |
| 13 | Le Pendeven YvesCFO | FNKOFunko, Inc. Open-market sale · 10b5-1 plan | SELL | $48K 6,862 sh | Sep 3, 2026 traded Aug 28, 2026 |
| 12 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $767K 7,215 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 11 | Barrett CherieSVP, Chief Accounting Officer |  DOCNDigitalOcean Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $421K 3,985 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 10 | Colburn Richard Edward IIIChief Product & Tech Officer |  ETSYETSY INCOpen-market sale · 10b5-1 plan | SELL | $89K 1,090 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 10 | Hawkins Matthew J.Director, Chief Executive Officer |  WAYWaystar Holding Corp.Open-market sale · 10b5-1 plan | SELL | $2.14M 82.5K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 10 | Colburn Richard Edward IIIChief Product & Tech Officer | ETSYETSY INC Open-market sale · 10b5-1 plan | SELL | $109K 1,344 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 9 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $965K 22.8K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $320K 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $449K 1,400 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 858 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 8 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $273K 2,600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Le Pendeven YvesCFO | FNKOFunko, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 1,833 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO |  NEMNEWMONT Corp /DE/Open-market sale · 10b5-1 plan | SELL | $477K 3,882 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Colburn Richard Edward IIIChief Product & Tech Officer | ETSYETSY INC Open-market sale · 10b5-1 plan | SELL | $40K 479 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $193K 600 sh | Sep 3, 2026 traded Sep 1, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K